News

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Vinay Prasad, named to lead the FDA agency tasked with regulating vaccines and gene therapy, has made controversial comments ...
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...
The question on many minds among FDA rank-and-file in attendance was: Which Prasad would show up? The 2010s Prasad -- a ...
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...